CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- 4 Grant or award Chief Financial Officer acquired 52,500 shares (grant or award)
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- SCHEDULE 13D Stake Beneficial Ownership Report
- 4 Open-market buy 10% owner bought 38,974,101 shares
- 3 Insider Initial Statement of Ownership
- 4 Planned sale CHIEF MEDICAL OFFICER sold 10,334 shares at $1.25 ($12,918)
- 4 Grant or award Director acquired 16,897,159 shares (grant or award)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 144 Insider Sale of Securities
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure · Other events
- SC 13G/A Stake Amended Statement of Ownership
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 875 shares (to pay taxes)
Page 12 of 24 · 464 filings